Published in J Clin Psychopharmacol on August 01, 2005
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology (Berl) (2008) 0.99
Psychiatry, neurology, and the role of the cerebellum. Psychiatry (Edgmont) (2010) 0.93
Neuropathological changes in the nucleus basalis in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.86
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. Curr Pharm Des (2014) 0.86
Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy. J Psychiatry Neurosci (2006) 0.82
Cholinergic circuits and signaling in the pathophysiology of schizophrenia. Int Rev Neurobiol (2007) 0.82
Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies. Front Psychiatry (2016) 0.75
Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry (2005) 3.78
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry (2003) 2.43
Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain (2002) 2.26
Unreality symptoms and volumetric measures of Heschl's gyrus and planum temporal in first-episode psychosis. Biol Psychiatry (2005) 2.11
The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res (2004) 1.87
Identical, but not the same: intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0T scanners. Neuroimage (2010) 1.75
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry (2005) 1.68
Cognitive effects of nicotine in humans: an fMRI study. Neuroimage (2003) 1.59
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study. Brain (2011) 1.55
Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin Diagn Lab Immunol (2002) 1.41
Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia. J Clin Psychopharmacol (2002) 1.39
Neural response to pleasant stimuli in anhedonia: an fMRI study. Neuroreport (2003) 1.33
A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr Res (2008) 1.28
Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res (2002) 1.27
Insight, distress and coping styles in schizophrenia. Schizophr Res (2007) 1.26
Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder. Behav Brain Res (2006) 1.25
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res (2006) 1.24
Decomposing the neural correlates of antisaccade eye movements using event-related FMRI. Cereb Cortex (2007) 1.22
Secretion and signaling activities of lipoprotein-associated hedgehog and non-sterol-modified hedgehog in flies and mammals. PLoS Biol (2013) 1.21
Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci (2004) 1.21
Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord (2008) 1.19
Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology (2005) 1.19
Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res (2003) 1.17
A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol (2006) 1.15
Regional cortical thinning in subjects with violent antisocial personality disorder or schizophrenia. Am J Psychiatry (2007) 1.15
The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry (2005) 1.14
Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res (2003) 1.14
The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci (2011) 1.14
Prefrontal cortex and insight in schizophrenia: a volumetric MRI study. Schizophr Res (2006) 1.12
Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) (2002) 1.11
Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biol Psychiatry (2005) 1.11
A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl) (2006) 1.10
Neural abnormalities during cognitive generation of affect in treatment-resistant depression. Biol Psychiatry (2003) 1.10
Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry (2004) 1.06
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry (2005) 1.05
A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biol Psychiatry (2004) 1.05
Neuroticism influences brain activity during the experience of visceral pain. Gastroenterology (2011) 1.04
Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr Res (2004) 1.04
Abnormal thalamocortical structural and functional connectivity in juvenile myoclonic epilepsy. Brain (2012) 1.04
Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology (2003) 1.04
Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol (2001) 1.03
Neurological basis of poor insight in psychosis: a voxel-based MRI study. Schizophr Res (2008) 1.02
Comparable fMRI activity with differential behavioural performance on mental rotation and overt verbal fluency tasks in healthy men and women. Exp Brain Res (2005) 1.02
De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia. Schizophr Res (2002) 1.02
Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol Psychiatry (2003) 1.01
Social cognition and its neural correlates in schizophrenia and autism. CNS Spectr (2004) 1.01
Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans. Neuroimage (2005) 1.00
The antisocial brain: psychopathy matters. Arch Gen Psychiatry (2012) 0.99
Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J Psychopharmacol (2005) 0.99
Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Schizophr Res (2002) 0.98
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation. Schizophr Res (2006) 0.98
Structural neural correlates of prosaccade and antisaccade eye movements in healthy humans. Neuroimage (2005) 0.97
Differential motivational responses to food and pleasurable cues in anorexia and bulimia nervosa: a startle reflex paradigm. Psychol Med (2006) 0.97
Smooth pursuit and antisaccade eye movements in siblings discordant for schizophrenia. J Psychiatr Res (2004) 0.96
Functional neural correlates of psychometric schizotypy: an fMRI study of antisaccades. Psychophysiology (2011) 0.96
Saccadic eye movements, schizotypy, and the role of neuroticism. Biol Psychol (2005) 0.96
Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI). J Psychopharmacol (2007) 0.95
Catechol-O-methyltransferase (COMT) val158met genotype is associated with BOLD response as a function of task characteristic. Neuropsychopharmacology (2008) 0.95
No gender differences in brain activation during the N-back task: an fMRI study in healthy individuals. Hum Brain Mapp (2009) 0.95
Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biol Psychiatry (2009) 0.94
Insight in first-episode psychosis. Psychol Med (2006) 0.94
Clustering probabilistic tractograms using independent component analysis applied to the thalamus. Neuroimage (2010) 0.94
Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia. Schizophr Bull (2010) 0.94
Dissociable functional connectivity changes during the Stroop task relating to risk, resilience and disease expression in bipolar disorder. Neuroimage (2011) 0.94
Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology (2010) 0.94
Brain volumes in familial and non-familial schizophrenic probands and their unaffected relatives. Am J Med Genet (2002) 0.93
Misattribution bias of threat-related facial expressions is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. Eur Psychiatry (2008) 0.93
Increases in regional subarachnoid CSF without apparent cortical gray matter deficits in schizophrenia: modulating effects of sex and age. Am J Psychiatry (2003) 0.93
Correlation-based multivariate analysis of genetic influence on brain volume. Neurosci Lett (2008) 0.93
Neuroticism and brain responses to anticipatory fear. Behav Neurosci (2007) 0.93
A neuropsychological investigation into violence and mental illness. Schizophr Res (2005) 0.92
Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol (2007) 0.92
Emotional decision-making and its dissociable components in schizophrenia and schizoaffective disorder: a behavioural and MRI investigation. Neuropsychologia (2008) 0.91
Startle gating in antipsychotic-naïve first episode schizophrenia patients: one ear is better than two. Psychiatry Res (2007) 0.91
Familial and disease specific abnormalities in the neural correlates of the Stroop Task in Bipolar Disorder. Neuroimage (2011) 0.91
Sex differences and individual differences in cognitive performance and their relationship to endogenous gonadal hormones and gonadotropins. Behav Neurosci (2005) 0.91
Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives. Biol Psychiatry (2003) 0.91
Coping styles predict responsiveness to cognitive behaviour therapy in psychosis. Psychiatry Res (2011) 0.91
Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study. Neuroimage (2005) 0.90
Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity. Neuroimage (2008) 0.90
Neural dysfunction and violence in schizophrenia: an fMRI investigation. Schizophr Res (2006) 0.90
Volumetric neural correlates of antisaccade eye movements in first-episode psychosis. Am J Psychiatry (2004) 0.87
Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. Psychopharmacology (Berl) (2003) 0.87